Computational insight into newly anomalous delayed fluorescence emitters based on D-A-A structures.

In variety of skeleton structures of delayed fluorescence molecular materials, the D-A-A type has been widely concerned recently for its improved double efficiency of reverse intersystem crossing process (RISC). Based on the D-A-A structure, eight new D-TRZ-nPO molecules (D = dihydrophenazine (DHPZ), phenothiazine (PTZ), phenoxazine (PXZ) and 9,9-dimethyl-9,10-dihydroacridan (DMAC), TRZ = triphenyltriazine, n = 1 or 2) with potential performance improvement have been deeply investigated by theoretical calculations. Interestingly, these molecules with the closing energy levels of high-lying excited states and charge transfer characters may perform rare high-lying excited state delayed fluorescence.

Theoretical study on the excited state decay properties of iron(ii) polypyridine complexes substituted by bromine and chlorine.

Transition metal iron(ii) polypyridyl complexes with quintet ground states were deeply investigated by density functional theory (DFT) and time-dependent density functional theory (TDDFT). Compared with the parent complex [Fe(tpy)] (tpy = 2,2':6',2''-terpyridine), the ground states of the complexes substituted by halogen atoms changed from singlet states to quintet states with rare high spin excited state lifetimes. The substituted complex [Fe(dbtpy)] (1) results in a high spin metal-ligand charge transfer lifetime of 17.

An evidence-based update on the pharmacological activities and possible molecular targets of Lycium barbarum polysaccharides.

Lycium barbarum berries, also named wolfberry, Fructus lycii, and Goji berries, have been used in the People's Republic of China and other Asian countries for more than 2,000 years as a traditional medicinal herb and food supplement. L. barbarum polysaccharides (LBPs) are the primary active components of L.

[Clinical observation on effect of Jieyu Anshen Decoction combined with aripiprazole in treating chronic schizophrenia].

Objective: To explore the efficacy and safety of Jieyu Anshen Decoction (JAD) combined with aripiprazole in treating chronic schizophrenia.

Methods: All 100 patients with chronic schizophrenia diagnosed according to CCMD-3 criteria were equally randomly assigned to the study group (treated with JAD combined with aripiprazole) and the control group (treated with aripiprazole alone) for 12 weeks. The efficacy and safety were evaluated by Positive and Negative Syndrome Scale (PANSS) and Treatment Emergent Side Effect Scale (TESS).